Baker Bros Reveals New Stake in Aquinox Pharmaceuticals (AQXP)

In a new filing with the SEC, Julian Baker and Felix Baker’s Baker Bros. Advisors revealed new stake in Aquinox Pharmaceuticals Inc (NASDAQ:AQXP). In Aquinox Pharmaceuticals, Baker Bros currently owns a total of 1.2 million shares, which make the holding equal to 12.1% of the common stock.

Pharmacyclics, Inc. (NASDAQ:PCYC)

Aquinox Pharmaceuticals, Inc (NASDAQ:AQXP) is a clinical-stage pharmaceutical company which discovers and develops novel drugs candidates for the treatment of inflammation and cancer.

Last month, the company closed its initial public offering of approximately 4.8 million shares at an offer price of $11.0 per share, which included 630,000 shares issued upon the exercise in full of the underwriters’ option to purchase additional shares. The total offering price is an estimated $53.1 million, excluding underwriting discounts, estimated expenses and commissions. This month, Zacks initiated coverage on Aquinox with a ‘Hold’ rating. Another analyst, Cowen and Company, initiated coverage on Aquinox Pharmaceuticals, Inc (NASDAQ:AQXP) with an ‘outperform’ recommendation at a target price of $30.0 per share.

Baker Bros Advisors, LLC, is located in New York and is a privately owned hedge fund. The fund has an equity portfolio of $7.1 billion, concentrated in the Healthcare sector. It was founded in the year 2000 by Felix Baker and Julian Baker. Dr. Felix J. Baker, who holds a B.S. in Biology and Ph.D in Immunology from Standford University, serves as the Managing Member of the fund. Co-founder, Julian C. Baker holds an A.B. Magna Cum Laude from the Harvard University, also serves as the managing member of the fund.

Baker Bros Advisors has been active until last month, reporting new and tweaked stakes in several companies. Last month, the fund upped positions in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) to 20.5 million shares and in Synageva Biopharma Corp (NASDAQ:TRMS) to 8.2 million shares. In January, Baker Bros disclosed holding 13.8 million shares in Genomic Health, Inc. (NASDAQ:GHDX) and 5.3 million shares in Celsus Therapeutics PLC (ADR) (OTCMKTS:CLSXD).

According to the fund’s latest 13F, top holdings of Baker Bros, as at the end of last year, were Pharmacyclics Inc (NASDAQ:PCYC), with a stake valued in excess of $922.3 million, followed by Seattle Genetic Inc. (NASDAQ:SGEN), of which it held around 20.7 million shares worth $827.2 million, and Incyte Corp (NASDAQ:INCY), in which it owned 14.8 million shares valued at more than $749.9 million.

Disclosure: none

Recommended Reading:

Southpoint Capital Advisors Ups Interest in Nexstar Broadcasting Group, Inc. (NXST)

Deerfield Management Boosts Stake In Insmed Incorporated (INSM)

Adage Capital and Maverick Capital are Bullish on Castlight Health Inc (CSLT)

Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

The Most Successful Reality TV Stars

Cheapest Cities to Visit in the US

Most Expensive Summer Camps

Most Expensive Animals in the World

Most Expensive Specialty Crops in the World

Movies That Took Ages to Make

The Longest Hollywood Films Ever Made

Most Expensive Concert Stages

The Richest Bands of all Time

10 Most Corrupt Countries 2013 List

10 Countries with the Highest Quality of Life Index

Most Expensive Mattresses in the World

5 Smallest Countries by Land Area

The Ultimate Heartbreak Songs

Richest Teenagers in the World

10 Most Haunted Places in America

10 Best Places to Retire in Florida East Coast

Top 10 Places to See Before You Die

Top 8 Countries in the World Where Justice Prevails

10 Richest States in America

15 Wealthiest Countries in the World

Richest Singers in the World

Most Expensive Tasting Menu in New York City

Most Expensive Baby Items in the World

Most Expensive Hotel Suites in Vegas

Most Expensive Brunch in New York City

Most Expensive Beef Cuts in the World

25 Best Colleges to Get a Job

Top 10 US Supermarkets

The 25 Most Dangerous Cities in the World to Visit

Most Expensive Xbox Games

Top 11 Cities Where Billionaires Live

Top 10 Most Charitable Companies in America

Most Expensive Seafood in the World

The 10 Wildest Conspiracy Theories

The 10 Best Job Markets in the US

Top 10 Accounting Scandals of All Time

The 25 Biggest Cities in the World

Top 10 Best Paying Virtual Jobs

Most Expensive Leather Shoes in the World

Top 6 Things to Buy in March

The 10 Most Stressful Jobs in America – 2014 List

Top 10 Jobs for Introverted People

Top 10 Honeymoon Destinations in the World

Top 10 Highest Paying Jobs in the World

Most Expensive Day-Care in New York City

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!